Average Co-Inventor Count = 2.35
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Children's Medical Center Corporation (18 from 1,036 patents)
2. Harvard College (2 from 2,961 patents)
3. Other (1 from 832,680 patents)
4. Scios Nova, Inc. (1 from 40 patents)
19 patents:
1. 12397037 - Methods and compositions for immunomodulation
2. 10456445 - Methods and compositions for immunomodulation
3. 8889620 - Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor
4. 8529905 - Soluble inhibitors of vascular endothelial growth factor and use thereof
5. 8153585 - Peptide antagonists of vascular endothelial growth factor and methods of use thereof
6. 7736655 - Soluble inhibitors of vascular endothelial growth factor and use thereof
7. 7731959 - Antagonists of neuropilin receptor function and use thereof
8. 7414027 - Peptide antagonists of vascular endothelial growth factor
9. 7335357 - Antagonists of neuropilin receptor function and use thereof
10. 7273612 - Soluble inhibitors of vascular endothelial growth factor and use thereof
11. 6777534 - Peptide antagonists of vascular endothelial growth factor
12. 6635421 - Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
13. 6235884 - Heparin binding mitogen with homology to epidermal growth factor (EGF)
14. 5811393 - Heparin binding mitogen with homology to epidermal growth factor (EGF)
15. 5789182 - System for assaying binding to a heparin-binding growth factor receptor